Patents for A61P 35 - Antineoplastic agents (221,099)
01/2005
01/05/2005EP1492524A1 Vitamin combination for providing protection during the chemotherapy and/or radiotherapy of malignant tumours
01/05/2005EP1492522A1 Ansamycin formulations and methods for producing and using same
01/05/2005EP1492512A1 Method for systemic drug delivery through the nail
01/05/2005EP1492501A1 Methods of using lamellar bodies for therapeutic purposes
01/05/2005EP1492487A2 Mitotic kinesin inhibitors
01/05/2005EP1492415A2 Method of improving absorption of vitamin e by a pet animal
01/05/2005EP1492414A2 Method and dietary composition for improving fat digestibility
01/05/2005EP1492413A2 Method and dietary composition for improving lipid digestibility
01/05/2005EP1411909B1 Pharmaceutical composition comprising (-)-secoisolariciresinol
01/05/2005EP1397386A4 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
01/05/2005EP1244440B1 Agonists specific for the peripheral cannabinoid receptor
01/05/2005EP1226126B1 Pyrimidine derivatives
01/05/2005EP1169035B1 Anti-tumor synergetic composition
01/05/2005EP1015014A4 Methods and compositions for inhibiting angiogenesis
01/05/2005EP0912196B9 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization
01/05/2005DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs
01/05/2005DE10327428A1 Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor Xa inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then aniline derivative
01/05/2005DE10326821A1 Pharmazeutische Kombinationspräparate zur Krebstherapie Pharmaceutical combination preparations for cancer therapy
01/05/2005CN1561390A PEG-modified uricase
01/05/2005CN1561389A Use of glycosylceramides as adjuvants for vaccines against infections and cancer
01/05/2005CN1561387A Probiotic bifidobacterium strains
01/05/2005CN1561344A Angiogenesis-inhibitory tripeptides, compositions and their methods of use
01/05/2005CN1561343A Soluble T cell receptor
01/05/2005CN1561232A Therapeutic agent comprising a B-subunit of a protein toxin
01/05/2005CN1561223A New drug
01/05/2005CN1561222A Matrix metalloprotease inhibitor
01/05/2005CN1561221A Novel medicinal herbal composition for treating liver diseases and HIV
01/05/2005CN1561219A Pharmaceutical compounds
01/05/2005CN1561216A Novel compounds
01/05/2005CN1561209A Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
01/05/2005CN1561208A Methods to mobilize progenitor/stem cells
01/05/2005CN1561207A Therapeutic delivery of carbon monoxide
01/05/2005CN1561201A Pharmaceutical compositions comprising colloidal silicon dioxide
01/05/2005CN1561199A Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
01/05/2005CN1560265A Preparation process of burduck protoglucoside of anti virus and antiptmour natural medicine
01/05/2005CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
01/05/2005CN1560082A Chimeric antibod of antihumon recombined basicity fibroblast growth factor and construction and using thereof
01/05/2005CN1560073A Analogy short peptide at growth factor antigen surface position of basicity fibroblast and its sieving and using
01/05/2005CN1560064A Derivative of vibothymidine and its preparation process and application
01/05/2005CN1560060A Synthesis for compound of diamine bridge linking ortho phenanthroline hydrous lanthanum (III) and anti-cancer activity thereof
01/05/2005CN1560050A Derivative of phenylamide pyrimidine and application thereof
01/05/2005CN1560044A Compound of 3, 15-dicarbonyl erythro mildew acid kind and its ester and salt
01/05/2005CN1559614A Dolysaccharide nanometer anticancer material and its preparation method
01/05/2005CN1559610A Vaccine curing for disease and its preparation method
01/05/2005CN1559602A Chinese medicine for strengthening antitumour thorapeutic effect of glossy ganoderma spore oil
01/05/2005CN1559601A Medicine for treating benign and malignant tumours
01/05/2005CN1559600A Anti-cancer pill
01/05/2005CN1559597A Disinfectant
01/05/2005CN1559592A Medicine for treating esophagus cancer
01/05/2005CN1559576A Chinese herbal medicine prescription for treating liver cancer, lung cancer, blood cancer, stomach cancer and cardia cancer and its formulating method
01/05/2005CN1559572A Compound Sanhuang powder
01/05/2005CN1559571A Jiangjie blood supplementing mixture and its application
01/05/2005CN1559563A Chinese medicne for preventing and curing cancer
01/05/2005CN1559545A Immune balancing energy restoring pill and its manufacturing method
01/05/2005CN1559518A Compound ginseng saponin biological preparation for inhibiting tumour and its preparation method
01/05/2005CN1559511A Chinese medicine for treating cancer and its preparation method
01/05/2005CN1559510A Compound medicine for treating Aids, cancer and its preparation method
01/05/2005CN1559454A Method for preparing Chinese herb medicine freezing-drying power-injection for treating tumor
01/05/2005CN1559453A Prepn. method of freezing-drying powder injection for anticancer made of Chinese herb medicines
01/05/2005CN1559443A Sturgeon chondroition capsule and instant granula prepn. method therefor
01/05/2005CN1559439A Method for preparing nanometer white arsenic magnetic liposome
01/05/2005CN1559425A Method for preparing Baicalin prepn. for external use
01/05/2005CN1559419A Application of saponin of Bolbostemma paniculatum Franquet for preparing medicine for treating malignant tumour
01/05/2005CN1559412A Freezing-drying powder-injection contg. sodium folinate, and its prepn. method
01/05/2005CN1559408A Leurocristine sulfate liposome compositions, and its prepn. method
01/05/2005CN1559404A Method for preparing artemisine and its liposoluble derivatives emulsion
01/05/2005CN1559401A Therapeutic use and compositions involving isoflavones
01/05/2005CN1559400A Method for preparing scutellarein liquid
01/05/2005CN1559392A Applicaton of gallic acid in prepn. of medicine for antitumor
01/05/2005CN1183250C Virus with specigic reproduction in tumor well and effective expression of tumor angiogenesis nihibitory factor and its construction method
01/05/2005CN1183162C Antitumor carboxyalkyl achyranthis polysaccharide and its preparation method and use
01/05/2005CN1183157C Method for distillig active protein liquid of scorpion
01/05/2005CN1183138C Process for promoting generation of 10-hydroxycamptothecin in the bud of camptotheca seed
01/05/2005CN1183136C Indoloquinazolinones
01/05/2005CN1183135C A novel crystalline form pyrrolo [2,3-d] pyrimidine antifolic agent and process therefor
01/05/2005CN1183133C 2-amino-6-anilino-purines and their use as medicaments
01/05/2005CN1183122C Dipeptide nitrile cathepsin K inhibitors
01/05/2005CN1183114C Quinoline derivatives and quinazoline derivatives
01/05/2005CN1182849C Freeze dried hydroxycamptothecin powder injection and its preparing process
01/05/2005CN1182846C Water soluble anticancer medicine taxol composite and its prepn method
01/04/2005US6838584 Estrogen receptor modulators
01/04/2005US6838574 Induction cell differentiation; leukemia therapy
01/04/2005US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
01/04/2005US6838558 Useful in the treatment and control of solid tumors
01/04/2005US6838547 Acryloyl derivatives of distamycin conjugated with glutathione; have antitumor activity and are thus useful in therapy in the treatment of cancer
01/04/2005US6838476 Imidazoles with anti-inflammatory activity
01/04/2005US6838472 Substituted urea retinoid agonists
01/04/2005US6838469 Pharmaceutical composition that exhibits reduced side-effects comprising O-(3-piperidino-2-hydroxy-1-propyl)nicotinic acid amidoxime and a pyrimidine derivative with known antitumor activity
01/04/2005US6838467 Dosing regimen
01/04/2005US6838466 Compounds for the treatment of inflammatory disorders
01/04/2005US6838464 Inhibitor of cyclin-dependent kinase
01/04/2005US6838460 Substituted phenylamidines medicaments containing said compounds and method for production thereof
01/04/2005US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles
01/04/2005US6838456 Condensed pyridoindole derivatives
01/04/2005US6838454 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
01/04/2005US6838453 Therapy for osteoporosis
01/04/2005US6838446 Anticancer agents; genetic engineered enzyme
01/04/2005US6838444 Using nucleic acid; repair interior ear hair
01/04/2005US6838439 Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists
01/04/2005US6838433 Peptides used as inhibitors of interleukin-6 (IL-6), for prophylaxis, therapy and/or diagnosis of blood disorders such as leukemia